Jesper Hoeiland serves as Executive at CONCERT PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Jesper Hoeiland has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 6, 2023 involved transacting 5,125 shares valued at $0.
Jesper Hoeiland currently holds 21,525 shares of CONCERT PHARMACEUTICALS, INC. (CNCE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jesper Hoeiland has been a net neutral trader of CNCE stock. They have purchased $0 and sold $0 worth of shares.
Jesper Hoeiland's most recent insider trade was on Mar 6, 2023, when they sold 5,125 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 9, 2022 | CNCE | $0 | Award | 16,400 | $N/A | Discretionary |
| Jun 10, 2021 | CNCE | $0 | Award | 5,125 | $N/A | Discretionary |